In addition to a potential lineage association, oncogenic KRAS signaling is the best predictor for a tumor suppressive role of AMBRA1 in LUAD [42], and oncogenic BRAF signaling correlates with AMBRA1 tumor suppressive activity in melanoma in DepMap. The gene discussed is KRAS; the disease is melanoma.